Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study.
Hassanein M, Hanif W, Malik W, Kamal A, Geransar P, Lister N, Andrews C, Barnett A. Hassanein M, et al. Among authors: hanif w. Curr Med Res Opin. 2011 Jul;27(7):1367-74. doi: 10.1185/03007995.2011.579951. Epub 2011 May 16. Curr Med Res Opin. 2011. PMID: 21568833
Digital health, cardiometabolic disease and ethnicity: an analysis of United Kingdom government policies from 2010 to 2022.
Thorlu-Bangura Z, Poole L, Sood H, Khan N, Stevenson F, Khunti K, Gill P, Sajid M, Hanif W, Bhala N, Modha S, Patel K, Blandford A, Banerjee A, Ramasawmy M. Thorlu-Bangura Z, et al. Among authors: hanif w. J Public Health Policy. 2023 Jun;44(2):179-195. doi: 10.1057/s41271-023-00410-z. Epub 2023 Apr 21. J Public Health Policy. 2023. PMID: 37085565 Free PMC article. Review.
Insulin avoidance and treatment outcomes among patients with a professional driving licence starting glucagon-like peptide 1 (GLP-1) agonists in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits.
Thong KY, Ryder RE, Cull ML, Walton C; ABCD Nationwide Exenatide and Liraglutide Audit Contributors. Thong KY, et al. Diabet Med. 2012 May;29(5):690-2. doi: 10.1111/j.1464-5491.2011.03475.x. Diabet Med. 2012. PMID: 21988449 No abstract available.
Burden of undiagnosed and suboptimally controlled diabetes in selected regions of India: Results from the SMART India population-level diabetes screening study.
Rajalakshmi R, Vasconcelos JC, Prevost AT, Sivaprasad S, Deepa M, Raman R, Ramasamy K, Anjana RM, Conroy D, Das T, Hanif W, Mohan V; SMART India Study Collaborators. Rajalakshmi R, et al. Among authors: hanif w. Diabet Med. 2023 Oct;40(10):e15165. doi: 10.1111/dme.15165. Epub 2023 Jun 21. Diabet Med. 2023. PMID: 37307016
Inequalities in the management of diabetic kidney disease in UK primary care: A cross-sectional analysis of a large primary care database.
Phillips K, Hazlehurst JM, Sheppard C, Bellary S, Hanif W, Karamat MA, Crowe FL, Stone A, Thomas GN, Peracha J, Fenton A, Sainsbury C, Nirantharakumar K, Dasgupta I. Phillips K, et al. Among authors: hanif w. Diabet Med. 2024 Jan;41(1):e15153. doi: 10.1111/dme.15153. Epub 2023 Jun 14. Diabet Med. 2024. PMID: 37223892
Correction to: Digital health, cardiometabolic disease and ethnicity: an analysis of United Kingdom government policies from 2010 to 2022.
Thorlu-Bangura Z, Poole L, Sood H, Khan N, Stevenson F, Khunti K, Gill P, Sajid M, Hanif W, Bhala N, Modha S, Patel K, Blandford A, Banerjee A, Ramasawmy M. Thorlu-Bangura Z, et al. Among authors: hanif w. J Public Health Policy. 2023 Jun;44(2):336-337. doi: 10.1057/s41271-023-00415-8. J Public Health Policy. 2023. PMID: 37165204 Free PMC article. No abstract available.
115 results